Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Current Oncology Reports|September 9, 2023
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular CarcinomaChristiana J Crook, Daneng LiSurgical Oncology Clinics of North America|March 26, 2016
Adjuvant and Neoadjuvant Therapy for Pancreatic CancerDaneng Li, Eileen M O'ReillySeminars in Oncology|March 2, 2015
Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinomaDaneng Li, Eileen M O'ReillyOncology (Williston Park, N.Y.)|November 21, 2024
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?Natasha Bahri, Christiana Crook, Daneng LiDrugs & Aging|March 25, 2022
Pharmacotherapeutic Management of Well-Differentiated Neuroendocrine Tumors in Older Patients: Current Status and Potential TherapiesChristiana Crook, Ya-Han Zhang, Daneng LiCancer Discovery|September 6, 2023
FGFR Inhibition: Understanding and Overcoming ResistanceAbhishek Tripathi, Daneng Li, Sumanta K PalOncology (Williston Park, N.Y.)|October 31, 2017
Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and ManagementAaron Lewis, Daneng Li, John Williams, et al.Clinics in Geriatric Medicine|November 29, 2015
Cancer and Aging: General Principles, Biology, and Geriatric AssessmentDaneng Li, Nienke A de Glas, Arti HurriaCancer Journal (Sudbury, Mass.)|July 22, 2017
Geriatric Assessment and Tools for Predicting Treatment Toxicity in Older Adults With CancerDaneng Li, Enrique Soto-Perez-de-Celis, Arti HurriaWorld Journal of Gastrointestinal Oncology|November 16, 2023
Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United StatesDaneng Li, Stephen B Gruber, Shrividya Iyer, et al.Pageof 11